Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingRozanne Arulanandam, Jean‐Simon Diallo, Cory Batenchuk et al.|Nature Communications|2015Cited by 69
Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlationBrian A. Keller, John C. Bell, Marie-Ève Wedge et al.|Journal of Cancer Research and Clinical Oncology|2021Cited by 4